Congestive Heart Failure And CoQ10

Since the 1960???s there have been numerous controlled clinical trials concerning the relationship between congestive heart failure and Coenzyme Q10 (CoQ10). As its name implies CoQ10 is a coenzyme that is necessary for the proper functioning of other substances, one of the most important of which is ATP (adenosine triphosphate). ATP is necessary for the production of cellular energy. By proxy CoQ10 is likewise essential for this process.

Clinical trials have attempted to study the relationship between CoQ10 and many chronic diseases including, but not limited to, heart disease, cancer and AIDS. But heart disease has gained the most attention; congestive heart failure being one of the primary subjects. Because heart muscle cells require so much energy to function and CoQ10 is at the core of the cellular energy process it makes sense to suspect that congestive heart failure might be linked to CoQ10 deficiency. With that theory in mind many studies like the ones that follow have been conducted. These trials have been presented in this essay in thumbnail format.

One early Japanese trial (1972) involved 197 patients with varying levels of severity of cardiac failure. The study reported significant improvement of cardiac function supplementing with 30 mg per day of CoQ10. Another Japanese study demonstrated similar results with 38 patients also supplementing with 30 mg. In 1985 a U.S. clinical study prescribed daily supplementation with 100 mg of the coenzyme for treatment periods of three months for patients with low ejection fraction measurements. The ejection fraction is the measure of the heart???s ability to pump blood. A low ejection fraction is a classic symptom of congestive heart failure. Again, significant improvements in heart function were reported. Other clinical trials followed prescribing the same level of supplementation with similar results.

Studies in the early 1990s showed improvement for patients suffering from ischemic cardiomyopathy (a low oxygen state usually due to obstruction) with supplemental levels of 200 mg per day. Supplementing with 100 mg per day demonstrated improvement for patients suffering from idiopathic dilated cardiomyopathy, an enlarged heart syndrome of unknown cause.

One of the largest trials of the 1990s involves 641 patients randomly divided into two groups. The first group received a placebo. The other group received CoQ10 supplements. During the one-year follow-up period 118 patients in the placebo group were hospitalized for heart failure compared to 73 in the group that received the supplements.

All of the preceding trials were relatively short-term studies. The level of improvement among patients varied depending on how long they had been suffering from some aspect of congestive heart failure. Through the years it has become increasing clear that the greatest improvements were shown in patients that had suffered from their condition the least amount of time.

In other words, the longer a person had been suffering from the disease before he or she received CoQ10 treatments the less improvement was demonstrated. People who had received treatments early in the development of the disease showed the most dramatic improvement often returning to normal heart function. Long-term sufferers received less relief and were less likely to return to full heart function. Whatever the reasons for this disparity in health improvement, it demonstrates the importance of receiving treatment as early as possible.

But what about long-term studies? Do they show the same marked improvement with similar treatment? In the short-term trials it was apparent that even high level supplementing with CoQ10 seemed to produce no ill effects. In order to determine if this is only true for short durations a number of long-term studies were conducted.

In 1990 observations were published concerning 126 patients with dilated cardiomyopathy. Unlike previously noted studies this one followed the patients??? progress for six years. Long-term benefits from CoQ10 supplementing were noticed with no harmful side effects. Similar observations were made in a trial involving 2,664 patients treated with CoQ10 at levels up to 150 mg per day.

A 1994 study involving 424 patients with a variety of myocardial (refers to the heart's muscle mass) diseases. Among these conditions were the following: Valvular heart disease (pertaining to dysfunction of heart valves), hypertension, diastolic dysfunction (failure of the heart to properly refill itself with blood), dilated cardiomyopathy (group of disorders where the heart muscle is weakened and enlarged and cannot pump effectively) and ischemic cardiomyopathy (low oxygen state usually due to obstruction of the arterial blood supply).

Patients were treated with an average of 240 mg of CoQ10 daily during their treatment period. They were then followed-up for up to eight years with an average follow-up period of 18 months. Overall results demonstrated measurable cardiac improvements in one month with maximum improvements at about six months. With continued CoQ10 treatment the improvement in most patients was sustained. However, discontinuing the treatment usually resulted in a decline of cardiac function with eventual return to pre-treatment conditions.

As always in the medical community many more studies will need to be conducted to determine the future of CoQ10 treatment. However, the research to date seems to support CoQ10 as a viable treatment for many diseases that are caused or exacerbated by inadequate production of cellular energy.

Greg holds degrees in science, divinity and philosophy and is currently an I.T. developer.

http://www.optimal-heart-health.com/coq10.html

scheduled maid service Highland Park ...

In The News:

Cybersecurity expert Morgan Wright says human skepticism remains the strongest defense against AI-driven phishing scams and voice cloning fraud schemes.

iPhone, Google Pixel and Samsung Galaxy each handle security updates differently, and one screen saying "up to date" may not tell the whole story.

Deborah Del Mastro heard what sounded like her daughter's terrified voice on the phone, launching a five-hour virtual kidnapping scam ordeal.

Hotel TV privacy risks go beyond forgotten passwords when you sign into Netflix or other streaming apps on shared devices you don't control.

Apple's iOS 27 Visual Intelligence now lets your iPhone search objects directly on screen, but Samsung Galaxy and Google Pixel have a head start.

x47.c Windows malware uses xAI's Grok to maintain persistence on infected PCs while stealing passwords, browser cookies and API keys from victims.

Frankie LaPenna fought three robots in a cage, including two modified EngineAI T800 humanoids that can kick with up to 850 pounds of force..

MacSync malware hides malicious commands inside iCloud calendar events to download additional payloads onto infected Macs without raising suspicion.

Joseph Holycross dismissed his racing heart for nearly two years until his Samsung Galaxy Watch detected atrial fibrillation and changed everything.

Home title fraud begins when criminals forge your signature on a deed. Here is how to check your own property records and set up free alerts.

Jeffrey Ladish, a former Anthropic security team member, warns AI agents are colluding and hacking with no reliable solution to keep them in check.

Instinct Concierge and Meta Muse can now place phone calls to businesses on your behalf, but the privacy and data access tradeoffs are significant.

Olivia Moore spent $100 to create a fake RushTok influencer using ChatGPT and MiniMax, and thousands of Bama Rush fans couldn't tell the difference.

RatHat Android malware uses AI to steal banking credentials, intercept two-factor authentication codes and reconstruct your PIN from touch inputs.

The Fox News AI Newsletter covers the latest artificial intelligence technology advancements, including the challenges and opportunities AI presents now and for the future.

Apple and Google password managers can flag compromised, weak and reused passwords on your phone before credential stuffing attacks can strike.

Researcher Peter Garrigan says Moonshot AI's Kimi model was manipulated into providing instructions for biological weapons and assassination plans.

iPhone, Google Pixel and Samsung Galaxy phones now offer call screening that asks unknown callers to identify themselves before your phone rings.

Ransomware can lock your irreplaceable photos and documents in seconds. A tested backup strategy and stronger cybersecurity habits are your best defense.

ShinyHunters claims it breached FBIJobs.gov and stole Social Security numbers, home addresses and sensitive assignment details of FBI personnel.

Find My iPhone, Google Find Hub and Samsung Find have critical tracking settings to enable now, before your phone ever goes missing or stolen.

The FTC proposed a new enforcement policy on personalized pricing, warning companies that hide how personal data shapes the prices shoppers see.

The $250 million Apple Siri AI settlement is now accepting claims, with eligible iPhone owners potentially receiving up to $95 per device.

ShareAScan turns T-shirts into scannable digital business cards with QR codes that link to profiles the owner can update anytime they choose.

BragJack research reveals how a single malicious browser extension could hijack Gemini, Perplexity Comet and Edge AI agents with zero clicks.

Congestive Heart Failure And CoQ10

Nutritional Supplements